‘China Week’ kicks off with US restrictions on Chinese biotech

0
8

The US House of Representatives is pursuing a string of bills aimed at reducing US reliance on Chinese tech and companies.

Among the first to pass was The Biosecure Act aimed at protecting the US medical supply chain by restricting federal governments from using several Chinese biotech firms within their contracts.

LEAVE A REPLY

Please enter your comment!
Please enter your name here